gray bg blue bg

New Study for People Ages 1–35 at Risk for Type 1 Diabetes – See If You Qualify!

Please fill in your details

Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid contact number.
Please select type of diabetes.
Kindly fill in above all mandatory fields

About the Study

Are you or your child at risk of developing Type 1 Diabetes? This study is testing a once-daily investigational oral medication (or placebo) to see if it can slow the immune system’s attack on insulin-producing cells and delay the onset of Stage 3 Type 1 Diabetes. There are currently no oral treatments available to prevent or delay this stage.

To take part in the study, participants should:

  • Be 1 to 35 years old
  • Have 2 or more diabetes-related autoantibodies (GADA, IAA, IA-2A, or ZnT8A)
  • Meet the definition for Stage 1b or Stage 2 Type 1 Diabetes
  • Have a body weight of at least 10 kg

For more information and details on the study

Call our team on (515) 329-5690

Please fill in your details

Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid contact number.
Please select type of diabetes.
Kindly fill in above all mandatory fields